SEC 13F Intelligence

Edmond De Rothschild Holding S.A. / PACB

Edmond De Rothschild Holding S.A.’s Pacific Biosciences Calif In Position

Does Edmond De Rothschild Holding S.A. own Pacific Biosciences Calif In (PACB)? Not currently — the last reported position was 10.68M shares worth $14M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$14M
Q3 2025
Shares
10.68M
% of Portfolio
+0.21%
Quarters Held
10
position exited

Position History PACB

Reported value by quarter
Q2 ’23: $6MQ2 ’23Q3 ’23: $7MQ4 ’23: $10MQ4 ’23Q1 ’24: $39MQ2 ’24: $23MQ2 ’24Q3 ’24: $35MQ4 ’24: $39MQ4 ’24Q1 ’25: $26MQ2 ’25: $17MQ2 ’25Q3 ’25: $14Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202510.68M$14M+0.21%
Q2 202513.37M$17M+0.26%
Q1 202521.86M$26M+0.45%
Q4 202421.35M$39M+0.67%
Q3 202420.31M$35M+0.56%
Q2 202416.74M$23M+0.39%
Q1 202410.51M$39M+0.66%
Q4 2023995.5K$10M+0.17%
Q3 2023806.9K$7M+0.14%
Q2 2023427.5K$6M+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Edmond De Rothschild Holding S.A.’s full portfolio or all institutional holders of PACB.